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The AP-2 complex is a key factor in the formation of endocytic
clathrin-coated vesicles (CCVs). AP-2 sorts and packages cargo
membraneproteins intoCCVs,binds thecoatproteinclathrin, and
recruits numerous other factors to the site of vesicle formation.
Structural information on the AP-2 complex and biochemical
work have allowed understanding its function on the molecular
level, and recent studies showed that cycles of phosphorylation
are key steps in the regulation of AP-2 function. The complex is
phosphorylated on both large subunits (- and 2-adaptins) as
well as at a single threonine residue (Thr-156) of the medium
subunit 2. Phosphorylation of 2 is necessary for efficient
cargo recruitment, whereas the functional context of the large
subunit phosphorylation is unknown. Here, we show that the
subunit phosphorylation of AP-2 exhibits striking differences,
with calculated half-lives of<1min for2,25min for2, and
70min for . We were also able to purify a phosphatase that
dephosphorylates the2 subunit. The enzyme is a member of
the protein phosphatase 2A family and composed of a cata-
lytic C subunit, a scaffolding A subunit, and a regulatory
B subunit. RNA interference knock down of the latter sub-
unit in HeLa cells resulted in increased levels of phosphoryl-
ated adaptors and altered endocytosis, showing that a specific
PP2A holoenzyme is an important regulatory enzyme in
CCV-mediated transport.
Internalization from the plasma membrane occurs by differ-
ent pathways, including uptake via clathrin-coated vesicles
(CCVs).4 Although it is obvious that clathrin coat assembly and
disassembly need to be tightly regulated both spatially and tem-
porally, little was known until now about the respective mech-
anisms that control the function of the many factors that are
identified. However, increasing evidence suggests that cycles of
phosphorylation/dephosphorylation are key events in the reg-
ulation of endocytic proteins (1). Indeed, the major endocytic
CCV constituents, clathrin and AP-2, are functionally regu-
lated by phosphorylation, as well as other factors including
dynamin 1, amphiphysins, synaptojanin, AP180, epsin, and
eps15, which are collectively grouped as dephosphins, that
become active in their dephosphorylated state (2).
Because AP-2 is a key factor in the formation of CCVs and
known for a long time to be phosphorylated, it is an ideal model
protein to analyze the functional consequences and regulatory
mechanisms of cycles of phosphorylation (3). The complex is
phosphorylated on themediumsubunit2 at a single threonine
residue (Thr-156), which ismediated in vitro by the two kinases
AAK1 andGAK (4–8). Both kinases phosphorylate not only2
but also the1 subunit of theAP-1 complex in vitro, and it is yet
unclear whether the two kinases act redundantly or distinc-
tively (9, 10). Besides this uncertainty, the current data show
that phosphorylation of the adaptor  subunits is a trigger for
high affinity binding to YXX sorting signals of cargo mem-
brane proteins (5, 11).
Although there is no evidence for phosphorylation of the
AP-2 2 subunit, both large subunits (- and 2-adaptins) are
phosphorylated, but it is not well establishedwhich residues are
modified. Using a phosphotyrosine-specific antibody, Sorkin
and coworkers identified an amino-terminal tyrosine (Tyr-6) as
a major target site for 2 phosphorylation (12), whereas more
recently others have identified Tyr-737 located in the ear
domain as an agonist-dependent Src kinase target (13). Not
only tyrosine residues have been identified as phosphorylation
target sites but also serine/threonine kinases such as the
recently identified CVAK104 (14) may impact on the phospho-
rylation status of 2-adaptin. Likewise, -adaptin is also phos-
phorylated, but no data are available on the target sites and the
involved kinase(s).
To get further insight into the role of AP-2 phosphorylation,
we used pulse-chase experiments to determine the phosphoryl-
ation turnover of the different AP-2 subunits. To our surprise,
the phosphorylation half-lives exhibited great differences,
ranging from1min in the case of2 to 25min for2 and70
min for the subunit. In addition, we purified a2-dephospho-
rylating enzyme activity from pig brain to homogeneity. The
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enzyme was identified as a protein phosphatase 2A (PP2A) and
composed of all three subunits that constitute a functional
holoenzyme: a catalytic C subunit, a scaffolding A subunit,
and a regulatory B subunit. Because the latter subunit is
assumed to determine intracellular location and substrate spec-
ificity, we knocked down the PP2A B subunit in HeLa cells by
RNAi. In the affected cells, we detected increased levels of 2
phosphorylation and altered endocytosis of transferrin, show-
ing that a particular PP2A is an important regulatory enzyme in
CCV-mediated transport.
EXPERIMENTAL PROCEDURES
Reagents and Antibodies—Monoclonal anti--adaptin was
from Alexis; antibodies against the PP2A subunits were from
Santa Cruz Biotechnology (rabbit anti-PP2A C/; rabbit anti-
PP2A A/; rabbit anti-PP1; rabbit anti-PP2B) and Millipore
GmbH (Schwalbach, Germany) (monoclonal anti-B). Phos-
phorylated 2 was detected with sheep antibodies (kindly pro-
vided by Elizabeth Smythe, University of Sheffield, UK) or with
serum from a rabbit that was immunized with a synthetic pep-
tide comprising phosphorylated Thr-156. Monoclonal anti-
bodies against clathrin and -adaptin were from BDTransduc-
tion Laboratories; anti-tubulin was from Molecular Probes.
Horseradish peroxidase-conjugated secondary antibodies used
for Western blotting and fluorochrome-labeled antibodies
were fromDianova (Hamburg, Germany). Protein phosphatase
1, 2A, and 2B proteins were obtained from Calbiochem. The
serine/threonine kinase inhibitor staurosporine was from Sigma;
thephosphatase inhibitorsocadaicacidandcalyculin-Awere from
Alexis; microcystin-agarose was obtained fromUpstate.
Cell Culture—HeLa and MDBK cells were grown at 37 °C
under standard cell culture conditions at 5% CO2 in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal calf
serum. Cells derived from transfection with the PP2A B-
RNAi vector were maintained in the presence of 200 g/ml
G-418.
Purification of CCVs and Immunoisolation of AP-2—The
CCV preparation and the AP-2 purification from them, as well
as the 32P labeling of AP-2 and its immunoisolation, were
exactly as described (5, 15).
In Vitro Dephosphorylation of AP-2—32P-labeled AP-2 (10–
15.000 cpm) was incubated in 50mMTris-HCl, pH 7.2, 100mM
NaCl, 1 mM dithiothreitol for 30 min at 37 °C without any fur-
ther additions (negative control) or with pig brain or HeLa
cytosol (5–100 g) or commercial protein phosphatase (0.05
units/sample) in a final volume of 100 l. Subsequently, the
samples were centrifuged, the supernatants were removed, and
the immunoadsorbed AP-2 was washed three times with
dephosphorylation buffer followed by SDS-PAGE and subse-
quent detection with autoradiography and Western blotting.
Purification of an AP-2-Dephosphorylating Enzyme from Pig
Brain—Pig brain cytosol obtained from the CCV purification
was precipitated with (NH4)2SO4 (35% final concentration),
followed by centrifugation at 10,000 rpm for 20 min in a JA10
rotor (Beckman Coulter). The derived supernatant was dia-
lyzed against buffer A (50mMTris, pH 7.4, 2mMMgCl2, 0.1mM
EGTA, 1.5 M (NH4)2SO4), followed by centrifugation as
described above. The fractionated cytosol was then applied to
hydrophobic interaction chromatography on a phenyl-Sepha-
rose column (1 30 cm) equilibrated in bufferA and connected
to a Perseptive Vision chromatography work station at a flow
rate of 4 ml/min. After sample application, the column was
extensively washed for 1 h with buffer A followed by gradient
elution using buffer A without ammonium sulfate. The
2-phosphorylating activity was collected in the third of three
peaks eluting at the end of the gradient. The fractions were
pooled and dialyzed against buffer B (50 mM Tris, pH 7.4, 2 mM
MgCl2, 0.1 mM EGTA, 5% glycerol), followed by strong anion
exchange chromatography using a 4.6  100-mm Source Q
column at a flow rate of 5 ml/min. After washing of the column
with 10 column volumes, proteins were eluted with a NaCl gra-
dient (0–0.5 M within 15 column volumes). The 2-dephos-
phorylating activity eluted in two consecutive fractions at250
mM salt. The fractions were pooled and dialyzed against buffer
B, followed by chromatography on a 4.6  100-mm DEAE-
Sepharose column equilibrated in buffer B at a flow rate of 1
ml/min. The 2-dephosphorylating activity was collected in
two fractions eluting at600mM salt. Fractions were pooled (2
ml) and concentrated to 200 l by centrifugation and then
applied to size exclusion chromatography using a 7.8 
300-mm G3000 SWXL column (Toso Haas) equilibrated in
buffer B at a flow rate of 0.5 ml/min. Only one major peak was
detectable that contained the 2-dephosphorylating activity
and eluted at a size of200 kDa. The eluted protein samplewas
kept at 4 °C until further use.
Immunoprecipitation of Cellular Adaptors—Pulse-chase
experiments were used to immunoprecipitate intracellular
phospho-AP-2. In brief, confluent cells on 3-cm dishes were
starved in phosphate-free medium followed by incubation with
220 Ci [32P]orthophosphate in 1 ml of phosphate-free Dul-
becco’s modified Eagle’s medium (5% serum) for 8.5 h (pulse).
Afterward, the labeling medium was removed and the cells
were washed and subsequently incubated for the indicated
chase periods in Dulbecco’s modified Eagle’s medium contain-
ing 10-fold excess phosphate. Control cells (t  0 min) were
collected after the pulse. All incubations were stopped by trans-
ferring the cells on ice and immediately exchanging the
medium for ice-cold homogenization buffer (25 mM Tris, 150
mM NaCl, 1 mM EDTA, pH 7.2). The cells were scraped in 1 ml
of homogenization buffer, collected by centrifugation for 5min
with 500 g, and then resuspended in 0.5 MTris, 150mMNaCl,
1 mM EDTA, pH 7.2, 1% Triton X-100, 10 nM calyculin, 10 nM
okadaic acid, 400 nM cantharidin, 900 nM endothal, protease
inhibitors and incubated for 30min, followed by centrifugation
for 30 min at 100,000  g to remove insoluble proteins. AP-2
was immunoprecipitated from the supernatants as described
(5) and resolved by conventional or 6 M urea-containing SDS-
PAGE (16). The subunit-incorporated radioactivity was quan-
tified from the dried gels using a FUJIX BAS 1000. In some
experiments AP-1 was precipitated as described above, using
monoclonal anti- adaptin antibodies.
The amount of radioactivity present in the labeling medium
before/after the pulse and in the medium after the chase was
determined by Cerenkov counting. By subtracting the values,
the intracellular radioactivity after the chase was determined.
For each experiment, the sums over time of the values of , 2,
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and 2 phosphorylation and intracellular radioactivity were
determined. To level these values from different experiments,
they were multiplied with a factor so that the corresponding
sums in each experiment were the same. Average values and
standard deviations were then generated and expressed in per-
cent of the control average values (t  0 min). Intracellular
radioactivity was interpolated with the sum of two e-functions
and differentiated, and the differentiationwas expressed in per-
cent of control, too. The phosphorylation half-lives were deter-
mined as described in the supplemental information. For the
data evaluation, Microsoft Excel and R program were used.
Data were interpolated with the formulas after the method of
least squares using the function “nls” in the R program.
Identification of Proteins byMass Spectrometry—For peptide
mass fingerprint analysis, the respective protein bands visible
after Coomassie staining were excised, cut in 1-mm small
pieces and subjected to in-gel digestion with trypsin (17),
desalted on C18 ZipTIP, and analyzed by matrix-assisted laser
desorption ionization time-of-flight mass spectrometry using
dihydrobenzoic acid as matrix and two autolytic peptides of
trypsin (m/z 842.51 and 2211.10) as internal standards. The
mass spectrometric data were used byMascot search algorithm
for protein identification in the NCBInr protein data base.
Suppression of PP2A B by RNA Interference—A plasmid-
based system was used to stably suppress the expression of the
PP2A B subunit in HeLa cells. The sequence GAACCCACT-
TCCTGCTTAG starting at position 1667 in the 3-untrans-
lated region of the humanBmRNA (NM_002717) was used as
a target. In brief, two complementary oligonucleotides were
synthesized containing the above target sequence followed by a
spacer of nine nucleotides, the target sequence in reverse ori-
entation, and a sequence of five thymidine bases as a terminator
of transcription. Both primers were annealed and cloned into
the pSHH plasmid (BioCarta) using SalI and XbaI restriction
sites. The plasmid, which also confers resistance to G418, was
transfected into HeLa cells using Effectene (Qiagen) as a trans-
fection reagent. Single clones were assayed by Western blot-
ting for suppression of the B subunit. Three clones in which
B expression was reduced by more than 80% were used for
further analysis. No obvious variation between the clones
was noticeable. To rule out unwanted side effects of vector-
based RNAi for the PP2A B subunit, we also used small
interference RNA oligos for the same and an additional tar-
get sequence (GTCTCATAGCAGAGGAGAA).
For rescue experiments, the coding sequence of the human
B-cDNA was cloned in-frame into the pCMV-3Tag-6 vector
(Stratagene) using HindIII and XhoI restriction sites. The final
insert codes for an amino-terminal triple repeat of the FLAG
tag (25 amino acids), followed by an additional spacer sequence
(30 amino acids) that was found to be essential for detection of
the tag sequence. Expression from the vector in HeLa cells was
not sensitive to the target sequence of vector-based RNAi and
the respective small interferenceRNAoligos, because the target
sequences in the 3-untranslated region were deleted from the
insert. The recombinant 3 FLAG-tagged B subunit was
detected by using tag-specific monoclonal (GenScript) or poly-
clonal (Delta Biolabs) antibodies. Integration of the tagged
recombinant B subunit into PP2A holoenzymes was verified
by detection of the PP2A C and A subunits in anti-FLAG anti-
body immunoprecipitates and by detection of the recombinant
subunit after capture of PP2A using agarose-immobilized
microcystin (see supplemental Fig. S1).
Endocytosis Experiments—Cells on glass coverslips were
serum-starved for 1 h in Dulbecco’s modified Eagle’s medium
with 0.5% serum albumin, washed with PBS, and incubated for
15min on ice in the presence of 20g/mlAlexa 546-conjugated
human transferrin (Tf), human Dil-LDL (20 g/ml), or rhoda-
mine-labeled dextran (2 mg/ml). Afterward, the cells were
either immediately fixed and processed for microscopy or first
incubated at 37 °C for 5 min to 2 h to monitor internalization.
For the biochemical analyses of Tf uptake, we used the bio-
tinylated protein. Parallel samples were incubated on ice with
Biotin-Tf for 30 min followed by washing with PBS. Then one
sample was collected for subsequent analysis of the total
amount of bound Tf. A second sample was left on ice and later
subjected to trypsin treatment to control the removal of surface
Tf. All other samples were incubated at 37 °C for up to 10 min
and then chilled on ice, washed with PBS, and incubated three
times for 5 min with trypsin to remove surface Tf. After wash-
ing with PBS, 1% serum, the cells of all samples were scraped,
collected by centrifugation, and homogenized in PBS, 1% Tri-
ton X-100. Subsequently, the biotin-Tf was immunoprecipi-
tated with streptavidin-agarose and detected by Western blot-
ting. A concentration series of biotin-Tf served as a control
for the amount of cell-internalized protein. Trypsin treatment
was able to remove 95% of all surface Tf. Endocytosis is
expressed as the amount of cell-associated biotin-Tf relative to
the total amount initially bound on ice.
Immunofluorescence—Cellswere seeded on glass coverslips 1
or 2 days before use. After fixation with 3% paraformaldehyde
for 20 min and blockage of remaining aldehyde groups with 50
mM NH4Cl in PBS for 10 min, the cells were permeabilized
using 0.5% saponin in PBS. Incubation with the primary anti-
bodies was carried out for 1 h at 37 °C, followed by incubation
for 15 min in 10% goat serum and incubation with the fluoro-
chrome-conjugated secondary antibodies for 30 min at 37 °C.
After washing with PBS and water, the samples were mounted
in Fluoromount (DAKO) and analyzed with a confocal laser
scanning microscope (Leica TCS-2 AOBS). For quantitative
analysis we determined the fluorescence intensity along identi-
cal longitudes of plasmamembrane profiles in an area of 200
200 m in HeLa and RNAi cells.
Miscellaneous—For inhibition of 2 dephosphorylation by
PP2A, a synthetic Thr-phosphorylated peptide was used
(CQ148SQITSQVTPGQIGWR162) that resembles the phos-
phorylation site in the AP-2 2 subunit with an additional cys-
teine at the amino terminus. The equivalent non-phosphoryla-
ted peptide and two other non-related peptides were used as
controls.
RESULTS ANDDISCUSSION
The AP-2 Subunits Exhibit Different Phosphorylation Turn-
over Rates—To gain insight into the phosphorylation turnover
of the different AP-2 subunits, cells were labeled with
[32P]phosphate for 8.5 h to mark a large pool of proteins. After
labeling, AP-2 was either immediately immunoprecipitated
A PP2AHoloenzymeDephosphorylates Clathrin Adaptors
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(t 0min) or the cells were chased for different periods of time
in phosphate-rich medium before AP-2 was collected. Subse-
quent to immunoprecipitation, AP-2 was subjected to SDS and
urea-containing SDS-PAGE to resolve-,2-, and2-adaptins
(Fig. 1A). Finally, the incorporated [32P]phosphate was quanti-
fied after autoradiography, and the amount of subunit-incorpo-
rated phosphate relative to the beginning of the chase (t  0
min) was plotted together with the export velocity of
[32P]inorganic phosphate from the cells (Fig. 1B, red curve).
Interestingly, we noticed a faster phosphorylation turnover
of 2 compared with 2 and -adaptin. To calculate realistic
phosphorylation turnover rates from the raw data shown in
Fig. 1A, the final mathematical equations had to consider the
continuously decreasing probability of 32P-protein rephospho-
rylation during the chase period (see supplemental information
for a detailed description). For the turnover of 2 phosphoryl-
ation we calculated a half-life of less than 1 min, while the two
large adaptor subunits exhibited half-lives of25 (2-adaptin)
and70min (-adaptin). The calculated phosphorylation half-
life of 2 fits well to the turnover rate of a forming clathrin-
coated vesicle (18, 19) that includes a cycle of 2 phosphoryla-
tion and dephosphorylation in the process of high affinity
binding to tyrosine-based sorting signal-containing membrane
cargo proteins (11).
The phosphorylation turnover of the two AP-2 large sub-
units wasmuch slower as comparedwith the2 subunit. In this
context it is important to note that we did not discriminate
between the potential amino acid residues involved. Using
phosphoamino acid analysis, Wilde and Brodsky (20) demon-
strated phosphorylation of - and 2-adaptin only on serine
residues whereas phosphorylation of tyrosine or threonine res-
idues was not detectable. However, the pattern of phosphoryl-
ation may change upon the status of the cells analyzed. Recent
data showed that stimulation of cells with epidermal growth
factor resulted in phosphorylation of 2-adaptin at Tyr-6 close
to the amino terminus (12). In a similar way, activation of vas-
cular smooth muscle cells by the G-protein-coupled receptor
agonist angiotensin II caused Src kinase-dependent phospho-
rylation of Tyr-737 located in the carboxyl-terminal appendage
domain of2-adaptin (13). The authors speculate that2 phos-
phorylation in this context is required to release AP-2 from
bound-arrestin; however, the details of this regulation remain
unknown. The data presented here for the phosphorylation
turnover of the AP-2 subunits were obtained from unstimu-
lated cells and resemble the experimental conditions used by
Wilde and Brodsky. Although the functional role of this “basic”
phosphorylation remains unclear, it may be of significance for
the regulation of AP-2 binding to its many partners (1). Phos-
phorylation of theAP-2 large subunits in their flexible, unstruc-
tured hinge regions or their appendage domainsmay directly or
indirectly be a prerequisite for the binding to other proteins, or
to terminate such binding. Future work will need to address
these possibilities on the molecular level.
Identification of a 2-Dephosphorylating Phosphatase—The
high affinity binding of 2 to tyrosine-based sorting signals of
membrane proteins requires its phosphorylation at Thr-156,
mediated by the adaptor-associated kinase AAK1 and/or the
cyclinG-associated kinase (10, 21, 22). In consequence, the reg-
ulatory cycle requires an antagonistic phosphatase. To charac-
terize and finally to identify this enzyme we used immunoiso-
lated AP-2 radiolabeled with [32P]phosphate at Thr-156 as a
substrate (see “Experimental Procedures” for details). Incuba-
tion of the labeled AP-2 with cytosol of different origin (e.g.
HeLa cells or pig brain) resulted in a signal decrease, indicative
of2 dephosphorylation (Fig. 2A). Small aliquots of the immu-
noisolated AP-2 prior and after cytosol incubation were used
for the detection of - and 2-adaptin and revealed that equal
amounts were present, clearly demonstrating that the loss of
signal in the autoradiogram was the result of dephosphoryla-
tion, ruling out loss of AP-2 in the assay. When the cytosol was
preincubated with sodium orthovanadate or EDTA/EGTA,
dephosphorylation of 2 was still effective, arguing against the
involvement of a phosphatase dependent on divalentmetal ions
or a tyrosine phosphatase (not shown). In contrast, calyculin-A,
microcystin, and ocadaic acid totally abolished 2 dephospho-
rylation at nanomolar concentrations (not shown), indicating
that a trimeric protein phosphatase like PP1 or PP2A may be a
more likely candidate. Indeed, PP2A was already characterized
as the enzymatic activity that mediates dephosphorylation of
the 1 subunit of the AP-1 complex (23), but no specific
enzyme was identified. Because most phosphatases are pre-
dominantly cytosolic we used pig brain cytosol as a starting
material for the purification of the 2-dephosphorylating
enzyme. Ammonium sulfate precipitation was first used to
deplete the cytosol of a substantial number of proteins. Under
these conditions, the enzyme remained in the soluble fraction
as verified by dephosphorylation of AP-2 using the assay
described above. The fractionated cytosol was then applied to
hydrophobic interaction chromatography, followed by collec-
tion of those fractions that contained 2-dephosphorylating
enzymatic activity. The pooled fractionswere further applied to
strong andweak anion exchange chromatography and finally to
FIGURE 1. Phosphorylation turn over of AP-2 subunits.AP-2was immuno-
precipitated from cells that had been pulse-labeled with [32P]phosphate or
after pulse labeling and chase periods of the indicated duration.A, autoradio-
gram derived from SDS and urea-SDS-PAGE showing the time-dependent
decay of AP-2 subunit phosphorylation. B, quantificationof thedata shown in
A. The subunit-incorporated [32P]phosphate after labeling (0 min) was set to
100%; all other values were related to that. The error bars indicate the varia-
tion between four independent experiments. The black traces represent
model simulations of half-lives ranging from 5 to 60 min.
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size exclusion chromatography. At this step the 2-dephos-
phorylating activity eluted in a single small peak that contained
four proteins (Fig. 2B), which were subjected to peptide mass
fingerprinting. With Mowse scores 200, one of the proteins
was identified as actin (Fig. 2C, asterisk); the other three pro-
teinswere identified as theA, B, andC subunits of PP2A. In
conclusion, we succeeded in the first purification of a PP2A
holoenzyme that mediates dephosphorylation of the 2 sub-
unit of AP-2.
The purified enzyme preparation was free of any contamina-
tion by PP1 or PP2B as verified by Western blotting, whereas
each PP2A subunit was unequivocally detected by antibodies of
the respective specificity (Fig. 2C). Based on the protein-spe-
cific activity toward 2, our purification resulted in a 5,000-
fold enrichment of the PP2A holoenzyme. Between different
preparations we noticed that the PP2A A and C subunits were
mostly present in stoichiometric amounts, while the amount of
the B subunit was not equivalent when analyzed by Coomassie
staining of the proteins.
The comparison of the purified enzyme with commercially
available dimeric and trimeric PP2A showed that only the latter
was able to dephosphorylate2, suggesting that presence of the
B subunit in the holoenzyme is important (Fig. 3A). As expected
for a classical PP2A, the enzyme preparation was sensitive to
the known inhibitors calyculin-A and ocadaic acid, with Ki val-
ues for the dephosphorylation of2 of 8 and 30 nM, respectively
(Fig. 3C). In addition, the dephosphorylation of 2 could be
effectively inhibited by a synthetic 16-mer peptide derived from
2 and including phosphorylated Thr-156, whereas addition of
a non-related peptide had no significant effect (Fig. 3D). To rule
out that any other contaminating phosphatase activity was
dephosphorylating the AP-2 2 subunit, we applied aliquots of
the PP2A purification to the depletion with either nonspecific
mouse IgG or monoclonal anti-PP2A C subunit IgG coupled to
protein-A-agarose. As shown in Fig. 3B, no PP2A was captured
with control IgG, whereas the anti-C subunit beadswere able to
deplete PP2A from the input almost quantitatively. The super-
natants of both depletions as well as a non-treated control were
then used in the 2-dephosphorylation assay. The supernatant
of the IgG beads as well as the non-treated PP2A preparation
exhibited equally high dephosphorylation activities (30 and
20% remaining phospho-2, respectively), whereas the anti-
PP2A supernatant lost its enzymatic activity (95% phospho-
2). We therefore conclude that indeed the PP2A holoenzyme
we identified dephosphorylates2 andnot any other enzymatic
impurity.
Knock Down of PP2A B Affects the Phosphorylation Status
of 2—The results described above show that the purified
PP2A holoenzyme mediates 2 dephosphorylation in vitro. To
analyze the significance of our findings for living cells, we sup-
pressed the expression of the PP2A B subunit in HeLa cells by
vector-based RNAi. In this context one should note that the
highly conserved PP2AA subunit associates with the C subunit
in a dimeric core enzyme that is thought to lack specificity for
substrate and intracellular localization (24, 25). Both functions
are mediated by the B subunit family of proteins. Four such
families have been characterized, each comprising four ormore
members. Because some of the B-proteins can be expressed as
FIGURE 2. Identification of a2-dephosphorylatingphosphatase.A, AP-2
phosphorylated on2was obtained by immunoisolation fromTris-extracted
CCVs that had been incubated with [-32P]ATP. Incubation with pig brain
cytosol resulted in substantial dephosphorylation of 2. Western blot analy-
sis for - and 2-adaptin revealed that no AP-2 was lost during the incuba-
tion.B, the2-dephosphorylatingenzymatic activitywaspurifiedby chroma-
tography from pig brain cytosol. All fractions of each step were tested for 2
dephosphorylation using the assay described in A. Positive fractions were
pooled and subjected to the next purification step. The final size exclusion
chromatography yielded a pool of activity, which was recovered from two frac-
tions eluting with a molecular mass of200 kDa. C, the Coomassie stain of the
purified phosphatase activity is shown in the first lane. Three of the purified pro-
teins were identified by peptidemass fingerprinting as the A, B, and C sub-
units of a PP2A holoenzyme; protein 4 (asterisk) was identified as actin. Western
blot analysis of the purified enzyme revealed the absence of PP1 (lane 2) and
PP2B/calcineurin (lane 3), whereas the three subunits of PP2A were positively
identified (lane 4; the specificity of the antibodies is indicated on the right).
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splice variants, the theoretical num-
ber of PP2A holoenzymes exceeds
70, each consisting of one of the two
A subunits ( or ), one of the two
catalytic C subunits ( or ), and
one of themany B subunits (26–28).
Because the holoenzyme purified by
us contained the B subunit of the
B55 family (29), it was the obvious
knockdown target in HeLa cells. As
shown in Fig. 4A, we could effi-
ciently and specifically suppress B
expression (5% residual protein),
while neither the PP2A catalytic
subunit nor other control proteins
were affected. As a control for the
specificity of suppression of the B
subunit, we generated a recombi-
nant subunit that was insensitive to
RNAi, because the cDNA was lack-
ing the RNAi target sequences
located in the 3-untranslated
region. The recombinant tagged B
subunit had a 50-amino acid amino
terminal extension including a 3
FLAG tag and was expressed in B
RNAi cells (Rescue) as confirmed by
detection with FLAG tag-specific
antibodies (Fig. 4A, lane 3). As
shown with antibodies against
endogenous B, the recombinant
subunit has a slightly higher molec-
ular mass, was exclusively detecta-
ble in the rescue cells, and was
slightly overexpressed (Fig. 4A,
compare lanes 1–3). We next
labeled cells with [32P]phosphate
and used equal amounts of protein
for precipitation of AP-2. As indi-
cated in Fig. 4B, the phospho-2
signal was increased by 2-fold in
AP-2 derived from the RNAi cells,
even though the same amounts of
AP-2were gained from all cell types.
Note that the original degree of 2
phosphorylation was restored in
RNAi cells expressing the recombi-
nant 3 FLAG B subunit, indica-
tive of its integration into functional
PP2A holoenzymes that dephos-
phorylate AP-2. This notion was
further corroborated by co-immu-
noprecipitation of the PP2A A and
C subunits with FLAG tag-specific
antibodies and by detection of the
recombinant B subunit in a pull-
down with agarose-immobilized
microcystin, which was used as an
FIGURE 3. Characterization of the 2-dephosphorylating PP2A. The purified PP2A holoenzyme was com-
paredwith commercially availabledimeric and trimeric formsof PP2A in the2dephosphorylation assay. Note
that only the trimeric holoenzymewas active (A). To further prove that dephosphorylation of2wasmediated
by the purified PP2A and not by a contaminating enzyme, a 1-g sample of the PP2A preparation (Input) was
subjected to depletion with either control IgG beads or beads coated with a monoclonal antibody specific for
the PP2A catalytic subunit (B). After depletion, the beads were collected and tested for PP2A by Western
blotting using two different antibodies. No PP2Awas captured by control beads, but only by anti-PP2A beads.
The supernatants of the depletion and a non-treated control were used for 2 dephosphorylation. Only the
supernatants of the control and the IgG beads were active, whereas that of the anti-PP2A beads lost all
2-phosphorylating activity. As shown in C andD, the activity of the purified enzymewas inhibited by increas-
ing concentrationsof twoknownPP2A inhibitors (C) andbyadditionof a synthetic Thr-156-phosphorylated2
peptide, but not by a non-related peptide (D), demonstrating that the AP-2 2 subunit is a substrate of the
purified PP2A holoenzyme.
FIGURE 4.Knock downof PP2AB impairs subunit dephosphorylation.As shown in A, expression of the
endogenous B subunit of PP2A was efficiently knocked down in HeLa cells by RNAi (see “Experimental
Procedures” for details), while three other marker proteins were not affected. Rescue cells express a recombi-
nant, RNAi-insensitive 3 FLAG-tagged B subunit as indicated by the slight shift inmobility and its detection
by anti-FLAG antibodies (compare lanes 2 and 3). When equal amounts of AP-2 (Western blot in B) were
precipitated from 32P-labeled cells, wenoticed a 2-fold increase of phospho-2 in RNAi cells (radiography in B),
suggesting an inhibition of the involved PP2A. Expression of the RNAi-insensitive 3 FLAG-tagged B was
sufficient to restore the original phosphorylation pattern of 2. In support of these results, cytosol prepared
from B RNAi cells was impaired in 2 dephosphorylation compared with cytosol from rescue cells and HeLa
cells or to incubation with the purified PP2A (C). Note that PP2A dephosphorylates not only 2 but also the
AP-11 subunit. The numbers represent the remaining amount of phospho- substrate after cytosol incuba-
tion as % of the untreated control in lane 1.
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affinity matrix for the capture of PP2A (see supplemental Fig.
S1). We therefore conclude that the pool of AP-2 phosphoryl-
ated at 2 is enlarged in B RNAi cells. Consistent with this
result, the cytosol from RNAi cells lost its 2-dephosphorylat-
ing activity (Fig. 4C) as compared with cytosol from HeLa cells
and rescue cells expressing recombinant B, or after incubation
with the purified PP2A. In the same set of experiments we used
32P-labeled AP-1 as a substrate, which was also dephosphoryl-
ated by the purified PP2A, but not by the RNAi cell-derived
cytosol. This observation is consistent with the results of the
Kornfeld group, who previously showed that dephosphoryla-
tion of the AP-1 1 subunit is PP2A-mediated (23), and sug-
gests that PP2A is an important regulatory enzyme of clathrin
adaptors.
Membrane protein binding in the process of clathrin-coated
vesicle formation at the plasma membrane is one of the impor-
tant functions of AP-2. We therefore analyzed the localization
of clathrin and AP-2 in HeLa and PP2A B RNAi cells and
monitored whether RNAi had any impact on endocytic pro-
cesses. As shown in Fig. 5, we noticed that the typical punctate
pattern ofAP-2 and clathrinwasmore pronounced in the RNAi
cells (compare panel C to F). Interestingly, the surface expres-
sion of the Tf receptor, which is widely used as a readout for
functional analyses of endocytic proteins (30–32), was also
increased by 2-fold in the RNAi cells as indicated after incuba-
tion with fluorescent transferrin on ice (compare Fig. 5, A and
B, quantification in G). The endocytosis of transferrin reached
similar levels (60% within 6 min) in HeLa and RNAi cells, but
the latter exhibited a significant higher rate of uptake (Fig. 5D).
The amount of intracellular-detectable transferrin slightly
decreased between 6 and 8min,most likely because some trans-
ferrin already recycled back to the cell surface within this
period. In contrast to our findings on the internalization of
transferrin, the receptor-mediated uptake of fluorescent low
density lipoprotein and the fluid phase endocytosis of rhoda-
mine-labeled dextran were not significantly affected when ana-
lyzed by immunofluorescence (not shown). In conclusion, our
results show that knock down of the PP2A B subunit affects
the amount of AP-2 and clathrin that was localized to coated
structures; however, endocytic processes were only marginally
affected. One explanation might be that imbalances in the reg-
ulatory cycle of AP-2 phosphorylation and dephosphorylation
may only have a small impact on the endocytic machinery in
general. Still, we are just beginning to explore the mechanisms
by which kinases and phosphatases regulate the functions of
endocytic proteins. Several kinases as well as PP1, PP2A, and
other phosphatases are present in coated vesicle preparations
(33–36), suggesting that the activities of these counteracting
enzymes have to be tightly controlled within the short period of
coated vesicle formation. Interestingly, the adaptor-associated
kinase AAK1 is active in a protein preparation liberated from
clathrin-coated vesicles by Tris extraction and easily phos-
phorylates AP-2 when ATP is added. In contrast, the PP2A in
the same preparation is inactive and unable to dephospho-
rylate AP-2.5Whether the PP2A activity is regulated by post-
translational modification(s), how the enzyme is recruited to
forming clathrin-coated vesicles, and whether it has other
substrates apart from AP-2 are some of the questions that we
need to address to get a deeper insight into the functional
regulation of endocytosis.
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